In contrast to PD-1 inhibitors, PD-L1 inhibitors are IgG1 antibodies, that have the biological function of recognizing pathogenic antigens and recognizing PD-L1 expressed on the surface of tumour cells. The gene discussed is CD274; the disease is neoplasm.